Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1989 Aug;44(8):654–659. doi: 10.1136/thx.44.8.654

Nedocromil sodium in adults with asthma dependent on inhaled corticosteroids: a double blind, placebo controlled study.

M F Bone 1, M M Kubik 1, N P Keaney 1, G D Summers 1, C K Connolly 1, P S Burge 1, R G Dent 1, G W Allan 1
PMCID: PMC462000  PMID: 2552600

Abstract

Eighty nine adults with asthma who were receiving inhaled corticosteroid and bronchodilator treatment took part in a double blind, randomised, placebo controlled trial of nedocromil sodium, 4 mg four times daily by inhalation. During a run in period of two to four weeks corticosteroid treatment was reduced when possible to produce a comparable level of symptoms across the trial population. The test treatment was then taken for four weeks, with the severity of asthma recorded daily by patients and assessed at two weekly hospital visits. There was an improvement in symptoms in the patients taking nedocromil sodium by comparison with those having the placebo, the differences being significant for diary card PEF readings, asthma symptom scores, and bronchodilator usage at night. The mean difference between the two groups was 18 l/min for PEF, 0.42 for daytime asthma score, and 1.73 puffs in 24 hours for bronchodilator usage. These results suggest that asthmatic patients who require inhaled steroids show better control of their asthma with the addition of nedocromil sodium than of placebo over a four week period after reduction of the dosage of their inhaled steroids.

Full text

PDF
654

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cairns H., Orr T. S. The development of a new agent for the treatment of inflammatory/allergic conditions. Int Arch Allergy Appl Immunol. 1987;82(3-4):513–517. doi: 10.1159/000234267. [DOI] [PubMed] [Google Scholar]
  2. Crimi E., Brusasco V., Brancatisano M., Losurdo E., Crimi P. Effect of nedocromil sodium on adenosine- and methacholine-induced bronchospasm in asthma. Clin Allergy. 1987 Mar;17(2):135–141. doi: 10.1111/j.1365-2222.1987.tb02331.x. [DOI] [PubMed] [Google Scholar]
  3. Dixon C. M., Fuller R. W., Barnes P. J. Effect of nedocromil sodium on sulphur dioxide induced bronchoconstriction. Thorax. 1987 Jun;42(6):462–465. doi: 10.1136/thx.42.6.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dorward A. J., Roberts J. A., Thomson N. C. Effect of nedocromil sodium on histamine airway responsiveness in grass-pollen sensitive asthmatics during the pollen season. Clin Allergy. 1986 Jul;16(4):309–315. doi: 10.1111/j.1365-2222.1986.tb01962.x. [DOI] [PubMed] [Google Scholar]
  5. Fyans P. G., Chatterjee P. C., Chatterjee S. S. A trial comparing nedocromil sodium (Tilade) and placebo in the management of bronchial asthma. Clin Allergy. 1986 Nov;16(6):505–511. doi: 10.1111/j.1365-2222.1986.tb01988.x. [DOI] [PubMed] [Google Scholar]
  6. Gonzalez J. P., Brogden R. N. Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease. Drugs. 1987 Nov;34(5):560–577. doi: 10.2165/00003495-198734050-00004. [DOI] [PubMed] [Google Scholar]
  7. Juniper E. F., Kline P. A., Morris M. M., Hargreave F. E. Airway constriction by isocapnic hyperventilation of cold, dry air: comparison of magnitude and duration of protection by nedocromil sodium and sodium cromoglycate. Clin Allergy. 1987 Nov;17(6):523–528. doi: 10.1111/j.1365-2222.1987.tb02048.x. [DOI] [PubMed] [Google Scholar]
  8. König P. Inhaled corticosteroids--their present and future role in the management of asthma. J Allergy Clin Immunol. 1988 Aug;82(2):297–306. doi: 10.1016/0091-6749(88)91015-9. [DOI] [PubMed] [Google Scholar]
  9. Lal S., Malhotra S., Gribben D., Hodder D. Nedocromil sodium: a new drug for the management of bronchial asthma. Thorax. 1984 Nov;39(11):809–812. doi: 10.1136/thx.39.11.809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Moqbel R., Cromwell O., Walsh G. M., Wardlaw A. J., Kurlak L., Kay A. B. Effects of nedocromil sodium (Tilade) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells. Allergy. 1988 May;43(4):268–276. doi: 10.1111/j.1398-9995.1988.tb00899.x. [DOI] [PubMed] [Google Scholar]
  11. Paananen M., Karakorpi T., Kreus K. E. Withdrawal of inhaled corticosteroid under cover of nedocromil sodium. Eur J Respir Dis Suppl. 1986;147:330–335. [PubMed] [Google Scholar]
  12. Robuschi M., Vaghi A., Simone P., Bianco S. Prevention of fog-induced bronchospasm by nedocromil sodium. Clin Allergy. 1987 Jan;17(1):69–74. doi: 10.1111/j.1365-2222.1987.tb02321.x. [DOI] [PubMed] [Google Scholar]
  13. Shaw R. J., Kay A. B. Nedocromil, a mucosal and connective tissue mast cell stabilizer, inhibits exercise-induced asthma. Br J Dis Chest. 1985 Oct;79(4):385–389. doi: 10.1016/0007-0971(85)90073-7. [DOI] [PubMed] [Google Scholar]
  14. Stead R. J., Cooke N. J. Adverse effects of inhaled corticosteroids. BMJ. 1989 Feb 18;298(6671):403–404. doi: 10.1136/bmj.298.6671.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Youngchaiyud P., Lee T. B. Effect of nedocromil sodium on the immediate response to antigen challenge in asthmatic patients. Clin Allergy. 1986 Mar;16(2):129–134. doi: 10.1111/j.1365-2222.1986.tb00756.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES